CLINICAL_TRIALS
trial_result
· 2021-02-15
Clinical Trial Update: Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest [Phase 2]
Summary
Phase 2 trial evaluating ubiquinol as a metabolic resuscitator after cardiac arrest has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beth Israel Deaconess Medical Center | Conditions: Cardiac Arrest | Phase 2 | Status: COMPLETED | Results posted: 2021-02-15